L Jaime Fitten1, Freddy Ortiz, Lynn Fairbanks, George Bartzokis, Po Lu, Eric Klein, Giovanni Coppola, John Ringman. 1. Easton Center for Alzheimer Disease Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Greater Los Angeles Veterans Affairs Healthcare System, Sepulveda Ambulatory Care Center, US Department of Veterans Affairs, Los Angeles, CA, USA; Department of Psychiatry Olive View, UCLA Medical Center, Los Angeles, CA, USA; Department of Psychiatry and Biobehavioral Sciences, School of Medicine, UCLA, Los Angeles, CA, USA.
Abstract
OBJECTIVE: Prior studies of US Hispanics, largely performed on the East Coast, have found a younger age of dementia onset than in White non-Hispanics. We performed a cross-sectional study to examine clinical and sociodemographic variables associated with age of dementia diagnosis in older Hispanics and White, non-Hispanics in southern California. METHODS: Two hundred ninety (110 Hispanic and 180 White non-Hispanic) community dwelling, cognitively symptomatic subjects, aged 50 years and older, were assessed and diagnosed with probable Alzheimer's disease or probable vascular dementia. Apolipoprotein E (APOE) genotype was assessed in a subset of cases. Analysis of variance and multiple stepwise linear regression were used to assess main effects and interactions of ethnicity with dementia severity (indexed by mini mental state examination scores) and other sociodemographic and clinical variables on age of dementia diagnosis. RESULTS: Hispanics were younger by an average of 4 years at the time of diagnosis, regardless of dementia subtype, despite a similar prevalence of the APOE ε4 genotype. The earlier age at diagnosis for Hispanics was not explained by gender, dementia severity, years of education, history of hypercholesterolemia, hypertension, or diabetes. Only ethnicity was significantly associated with age of onset. CONCLUSIONS: These findings confirm that US Hispanics living in the southwestern USA tend to be younger at the time of dementia diagnosis than their White non-Hispanic counterparts. As this is not explained by the presence of the APOE ε4 genotype, further studies should explore other cultural, medical, or genetic risk factors influencing the age of dementia onset in this population.
OBJECTIVE: Prior studies of US Hispanics, largely performed on the East Coast, have found a younger age of dementia onset than in White non-Hispanics. We performed a cross-sectional study to examine clinical and sociodemographic variables associated with age of dementia diagnosis in older Hispanics and White, non-Hispanics in southern California. METHODS: Two hundred ninety (110 Hispanic and 180 White non-Hispanic) community dwelling, cognitively symptomatic subjects, aged 50 years and older, were assessed and diagnosed with probable Alzheimer's disease or probable vascular dementia. Apolipoprotein E (APOE) genotype was assessed in a subset of cases. Analysis of variance and multiple stepwise linear regression were used to assess main effects and interactions of ethnicity with dementia severity (indexed by mini mental state examination scores) and other sociodemographic and clinical variables on age of dementia diagnosis. RESULTS: Hispanics were younger by an average of 4 years at the time of diagnosis, regardless of dementia subtype, despite a similar prevalence of the APOE ε4 genotype. The earlier age at diagnosis for Hispanics was not explained by gender, dementia severity, years of education, history of hypercholesterolemia, hypertension, or diabetes. Only ethnicity was significantly associated with age of onset. CONCLUSIONS: These findings confirm that US Hispanics living in the southwestern USA tend to be younger at the time of dementia diagnosis than their White non-Hispanic counterparts. As this is not explained by the presence of the APOE ε4 genotype, further studies should explore other cultural, medical, or genetic risk factors influencing the age of dementia onset in this population.
Authors: G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman Journal: Neurology Date: 1993-02 Impact factor: 9.910
Authors: Yong-Fang Kuo; Mukaila A Raji; Kyriakos S Markides; Laura A Ray; David V Espino; James S Goodwin Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112
Authors: Irving E Vega; Laura Y Cabrera; Cassandra M Wygant; Daniel Velez-Ortiz; Scott E Counts Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Hector M González; Wassim Tarraf; Kevin A González; Myriam Fornage; Donglin Zeng; Linda C Gallo; Gregory A Talavera; Martha L Daviglus; Richard B Lipton; Robert Kaplan; Alberto R Ramos; Melissa Lamar; Jianwen Cai; Charles DeCarli; Neil Schneiderman Journal: Diabetes Care Date: 2020-03-05 Impact factor: 19.112
Authors: John M Ringman; Michael C Sachs; Yan Zhou; Sarah E Monsell; Jeffrey L Saver; Harry V Vinters Journal: JAMA Neurol Date: 2014-07-01 Impact factor: 18.302
Authors: Jamaica R Rettberg; Ha Dang; Howard N Hodis; Victor W Henderson; Jan A St John; Wendy J Mack; Roberta Diaz Brinton Journal: Neurobiol Aging Date: 2016-01-29 Impact factor: 4.673